What does CUSIP 74365U107 represent in this 13F holders report?

CUSIP 74365U107 is the security identifier for TARA - Protara Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TARA - Protara Therapeutics, Inc. - Common Stock in Q1 2023?

28 institutional investors reported TARA - Protara Therapeutics, Inc. - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

Protara Therapeutics, Inc. - Common Stock (TARA)

CUSIP: 74365U107

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock
Total 13F shares: 5,503,158
Total 13F value: $16,886,987
Share change: +25,045
SEC-reported price per share: $3.13
Number of holders: 28
Value change: +$77,617
Number of buys: 6
Number of sells: 8
Shares outstanding: 55,913,202

Security key

74365U107

Report period

Q1 2023

Institutions

Top holders

TARA full security history Ownership snapshot Full 13F holder table Protara Therapeutics, Inc. SEC filings Protara Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TARA - Protara Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Opaleye Management Inc.

Disclosed value leader

Opaleye Management Inc.

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

Opaleye Management Inc. leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Opaleye Management Inc.'s linked filing trail.

Comparable ownership Top 5

Opaleye Management Inc. 4.8%

ORBIMED ADVISORS LLC 1.5%

VANGUARD GROUP INC 0.76%

PERCEPTIVE ADVISORS LLC 0.52%

Boxer Capital, LLC 0.37%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Opaleye Management Inc.	13F Company 13F	4.8%	$7,216,152 2,692,594 shares	—	31 Dec 2022
ORBIMED ADVISORS LLC	13F Company 13F	1.5%	$2,226,118 830,641 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	0.76%	$1,146,000 427,612 shares	—	31 Dec 2022
PERCEPTIVE ADVISORS LLC	13F Company 13F	0.52%	$777,337 290,051 shares	—	31 Dec 2022
Boxer Capital, LLC	13F Company 13F	0.37%	$560,728 209,227 shares	—	31 Dec 2022
BAKER BROS. ADVISORS LP	13F Company 13F	0.36%	$535,118 199,671 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,503,158

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %